Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
DJ.1.3SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BQ.1.1.73SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
DW.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
XAKSYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BQ.1.30SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BQ.1.1.50SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BA.5.1.36SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BF.39.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BF.5.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BA.5.2.46SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BA.5.7SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
CU.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
DR.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
FP.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
EE.5SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BQ.1.1.52SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BA.5.2.32SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BQ.1.1.58SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
CF.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
DN.3.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
DJ.1.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BW.1.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BF.10.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BQ.1.15.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
XCBSYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BQ.1.15.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BA.5.2.40SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BQ.1.1.68SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BF.7.26SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BQ.1.1.25SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BQ.1.1.51SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BQ.1.1.26SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BQ.1.1.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BQ.1.1.76SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
CK.1.4SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BQ.1.1.11SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BA.4.6.4SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BQ.1.3SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BQ.1.5SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BA.2.75.5SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BF.7.8SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BQ.1.1.40SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
DM.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BQ.1.1.60SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BQ.1.1.49SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
CK.2.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BQ.1.13SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.9.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
XDK.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.49.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used